Rankings
▼
Calendar
TARS Q2 2018 Earnings — Tarsus Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
TARS
Tarsus Pharmaceuticals, Inc.
$3B
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$337,500
Net Income
-$329,750
EPS (Diluted)
$-0.08
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$295,750
Free Cash Flow
-$297,500
Stock-Based Comp.
$2,250
← FY 2018
All Quarters
Q3 2019 →
